Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus

References

• Chiappetta DA, Alvarez-Lorenzo C, Rey-Rico A, et al. N-alkylation of poloxamines modulates micellar assembly and encapsulation and release of the antiretroviral efavirenz. Eur J Pharm Biopharm 2010;76:24–37.
   PubMed Web of Science ®Google Scholar
• Pereira SA, Branco T, Caixas U, et al. Intra-individual variability in efavirenz plasma concentrations supports therapeutic drug monitoring based on quarterly sampling in the first year of therapy. Ther Drug Monit 2008;30:60–6.
   PubMed Web of Science ®Google Scholar
• Madhusudhan A, Reddy B, Venkatesham M, Veerabhadram G. Design and evaluation of efavirenz loaded solid lipid nanoparticles to improve the oral bioavailbility. Int J Pharm Pharm Sci 2012;2:84–9.
   Google Scholar
• Katata L, Tshweu L, Naidoo S, et al. Design and formulation of nano-sized spray dried efavirenz-part I: influence of formulation parameters. J Nanoparticle Res 2012;14:1247–54.
   Web of Science ®Google Scholar
• Seremeta KP, Chiappetta DA, Sosnik A. Poly(ε-caprolactone), Eudragit®RS 100 and poly(ε-caprolactone)/Eudragit®RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz. Colloids Surf B Biointerfaces 2013;102:441–9.
   PubMed Web of Science ®Google Scholar
• Pinto EC. Estudo de dissolução intrínseca de Efavirenz como ferramenta para antecipação de sua biodisponibilidade. Rio de Janeiro: Faculdade de Farmácia, Universidade Federal do Rio de Janeiro; 2012.
   Google Scholar
• da Costa MA, Seiceira RC, Rodrigues CR, et al. Efavirenz dissolution enhancement I: co-micronization. Pharmaceutics 2013;5:1–22.
   Google Scholar
• Patel GV, Patel VB, Pathak A, Rajput SJ. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation. Drug Dev Ind Pharm 2014;40:80–91.
   PubMed Web of Science ®Google Scholar
• Chadha R, Arora P, Bhandari S, Jain DVS. Effect of hydrophilic polymer on complexing efficiency of cyclodextrins towards efavirenz-characterization and thermodynamic parameters. J Incl Phenom Macrocycl Chem 2012;72:275–87.
   Web of Science ®Google Scholar
• Lamba SS, Chowdary KPR. A factorial study on formulation development of efavirenz tablets employing β Cyclodextrin – Poloxamer 407 – PVPK30. IJPSR 2012;3:782–7.
   Google Scholar
• Chiappetta DA, Hocht C, Taira C, Sosnik A. Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability. Nanomedicine 2010;5:11–23.
   PubMed Web of Science ®Google Scholar
• Deshmukh A, Kulakrni S. Novel self micro-emulsifying drug delivery systems (SMEDDS) of efavirenz. J Chem Pharm Res 2012;4:3914–19.
   Google Scholar
• Chadha R, Saini A, Arora P, et al. Cocrystals of efavirenz with selected conformers: preparation and characterization. Int J Pharm Pharm Sci 2012;4:244–50.
   Google Scholar
• Madhavi BB, Chatanya CK, Madhu MN, et al. Dissolution enhancement of efavirenz by solid dispersion and PEGylation techniques. Int J Pharm Investig 2011;1:29–34.
   PubMedGoogle Scholar
• Venkateswara-Reddy B, Ramana-Murthy KV. Enhancement of dissolution rate of efavirenz by solid dispersion technique. IJPBS 2012;2:185–90.
   Google Scholar
• Alves LDS, de La Roca Soares MF, de Albuquerque CT, et al. Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods. Carbohydr Polym 2014;104:166–74.
   PubMed Web of Science ®Google Scholar
• Sathigari SK, Radhakrishnan VK, Davis VA, et al. Amorphous-state characterization of efavirenz-polymer hot-melt extrusion systems for dissolution enhancement. J Pharm Sci 2012;101:3456–64.
   PubMed Web of Science ®Google Scholar
• Chowdary KPR, Enturi V. Preclinical pharmacokinetic evaluation of Efavirenz solid dispersions in two new modified starches. J Appl Pharm Sci 2013;3:S89–S92.
   Google Scholar
• Shamma RN, Basha M. Soluplus®: a novel polymeric solubilizer for optimization of carvedilol solid dispersions: formulation design and effect of method of preparation. Powder Technol 2013;237:406–14.
   Web of Science ®Google Scholar
• Reintjes T, Koltzenburg S, Karl M, et al. Soluplus®. In: Reintjes T, ed. Solubility enhancement with BASF pharma polymers – solubilizer compendium. Vol. 5 BASF: Germany; 2011;67–71.
   Google Scholar
• Dhirendra K, Lewis S, Udupa N, Atin K. Review solid dispersions: a review. Pak J Pharm Sci 2009;22:234–46.
   PubMed Web of Science ®Google Scholar
• Dobry DE, Settel DM, Baumann JM, et al. A model-based methodology for spray-drying process development. J Pharm Innov 2009;4:133–42.
   PubMed Web of Science ®Google Scholar
• Repka MA, Shah S, Lu J, et al. Melt extrusion: process to product. Expert Opin Drug Deliv 2012;9:105–25.
   PubMed Web of Science ®Google Scholar
• Paudel A, Worku ZA, Meeus J, et al. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Int J Pharm 2013;453:253–84.
   PubMed Web of Science ®Google Scholar
• Hansen CM. Hansen solubility parameters. A user’s handbook. 2nd edn. Boca Raton, MA: CRC Press; 2007.
   Google Scholar
• Van Krevelen DW, Hoftyzer PJ. Properties of polymers. Their estimation and correlation with chemical structures. 2nd edn. New York: Elsevier; 1976.
   Google Scholar
• Gordon M, Taylor JS. Ideal copolymers and the second-order transitions of synthetic rubbers. I. Noncrystalline copolymers. J Appl Chem 1952;2:493–500.
   Web of Science ®Google Scholar
• USP35. United States Pharmacopeia 35 – National Formulary 30; 2012.
   Google Scholar
• Panikumar A, Sunitha G, Venkat Raju Y, et al. Development of biorelevant efavirenz and its formulations. Asian J Pharm Clin Res 2012;5:220–3.
   Google Scholar
• Kuentz M. Drug absorption modeling as a tool to define the strategy in clinical formulation development, towards integrated ADME prediction: past, present, and future. AAPS J 2008;10:473–9.
   PubMed Web of Science ®Google Scholar
• Mendyk A, Jachowicz R, Fijorek K, et al. KinetDS: an open source software for dissolution test data analysis. Dissolution Technol 2012;19:6–11.
   Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25–35.
   Web of Science ®Google Scholar
• Greenhalgh DJ, Williams AC, Timmins P, York P. Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci 1999;88:1182–90.
   PubMed Web of Science ®Google Scholar
• Mahapatra S, Thakur TS, Joseph S, et al. New solid state forms of the anti-HIV drug efavirenz. Conformational flexibility and high Z’ issues. Cryst Growth Des 2010;10:3191–202.
   Web of Science ®Google Scholar
• Yu M, Ocando JE, Tromebetta L, Chatterjee P. Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acid. AAPS PharmSciTech 2014;16:384–97.
   PubMed Web of Science ®Google Scholar
• Zallen R. The formation of amorphous solids. In: The physics of amorphous solids. New York: Wiley; 1983: 1–22.
   Google Scholar
• Janssens S, De Zeure A, Paudel A, et al. Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and Eudragit E100. Pharm Res 2010;27:775–85.
   PubMed Web of Science ®Google Scholar
• Homayouni A, Sadeghi F, Nokhodchi A. Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods. Iran J Pharm Res 2015;14:35–50.
   PubMed Web of Science ®Google Scholar
• Koh PT, Chuah JN, Talekar M, et al. Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems. Indian J Pharm Sci 2013;75:291–301.
   PubMed Web of Science ®Google Scholar
• Wang FJ, Wang CH. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents. J Control Release 2002;81:263–80.
   PubMed Web of Science ®Google Scholar
• Rassu G, Gavini E, Spada G, et al. Ketoprofen spray-dried microspheres based on Eudragit RS and RL: study of the manufacturing parameters. Drug Dev Ind Pharm 2008;34:1178–87.
   PubMed Web of Science ®Google Scholar
• Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res 2008;25:999–1022.
   PubMed Web of Science ®Google Scholar
• Maurin MB, Rowe SM, Blom K, Pierce ME. Kinetics and mechanism of hydrolysis of efavirenz. Pharm Res 2002;19:517–22.
   PubMed Web of Science ®Google Scholar
• Ilardia-Arana D, Kristensen HG, Müllertz A. Biorelevant dissolution media: aggregation of amphiphiles and solubility of estradiol. J Pharm Sci 2006;95:248–55.
   PubMed Web of Science ®Google Scholar
• Thakral NK, Ray AR, Bar-Shalom D, et al. Soluplus-solubilized citrated camptothecin—a potential drug delivery strategy in colon cancer. AAPS PharmSciTech 2012;13:59–66.
   PubMed Web of Science ®Google Scholar
• Torrado S, Torrado S, Torrado JJ, Cadorniga R. Preparation, dissolution and characterization of albendazole solid dispersions. Int J Pharm 1996;140:247–50.
   Web of Science ®Google Scholar
• Zingone G, Rubessa F. Release of carbamazepine from solid dispersions with polyvinylpyrrolidone/vinylacetate copolymer (PVP/VA). STP Pharma Sci 1994;4:122–7.
   Google Scholar
• Wahlgren M, Christensen KL, Jorgensen EV, et al. Oral-based controlled release formulations using poly (acrylic acid) microgels. Drug Dev Ind Pharm 2009;35:922–9.
   PubMed Web of Science ®Google Scholar
• Singhvi G, Singh M. Review: in vitro drug release characterization models. Int J Pharm Stud Res 2011;2:77–84.
   Google Scholar
• Punčochová K, Heng JYY, Beránek J, Štěpánek F. Investigation of drug–polymer interaction in solid dispersions by vapour sorption methods. Int J Pharm 2014;469:159–67.
   PubMed Web of Science ®Google Scholar